STAT+: China expected to soon surpass U.S. in bio innovation

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. It’s an exciting week not only for biotech M&A, but also for my city (Chicago) as we gear up for our big game this Saturday.

Going into JPM, it’s good to be a pharma CEO

Next week’s JPM conference will likely be the most jubilant for Big Pharma in years.

Continue to STAT+ to read the full story…

​STAT Pharma: The science and business of new drug development

Leave a Reply

Your email address will not be published. Required fields are marked *